home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410m.zip
/
M94A2400.TXT
< prev
Wrap
Text File
|
1994-10-25
|
2KB
|
30 lines
Document 2400
DOCN M94A2400
TI Viral hepatitis in the HIV-infected woman.
DT 9412
AU Kloser P; Passanante M; Mayberry B; Gill C; Cowan J; UMDNJ.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):312 (abstract no. PC0176). Unique
Identifier : AIDSLINE ICA10/94370175
AB OBJECTIVE: To compare the incidence and effect of viral hepatitis
between ever intravenous (IVU) drug use and never intravenous drug use
among HIV-infected women in NWAC (Newark Women's AIDS Clinic). METHOD: A
random retrospective chart review of 146 HIV-infected women at
comparable disease stages with and without IVU history. RESULTS: TABULAR
DATA, SEE ABSTRACT VOLUME. CONCLUSION: HBV or HCV are present in close
to 40% of NWAC patients and is a problem in our practice. HCV infection
is equally likely in IVU and non-IVU while HBV alone or with HCV is more
likely in IVU. A large percentage of those with HBV are surface antibody
negative. Many women show evidence of liver disease via elevated
transaminase levels. Implications include: HIV testing of those with
evidence of HBV and/or HCV; HBV vaccine for those without positive
antibody and appropriate changes in prescribing practice in HIV-infected
women with liver disease.
DE Female Hepatitis B/*COMPLICATIONS/DIAGNOSIS Hepatitis
C/*COMPLICATIONS/DIAGNOSIS Human HIV
Infections/*COMPLICATIONS/DIAGNOSIS Retrospective Studies Substance
Abuse, Intravenous/COMPLICATIONS MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).